EUVIMEDEUVIMED entdecken
Open Access

Inhibition of IL-1 Ameliorates Cardiac Dysfunction and Arrhythmias in a Murine Model of Kawasaki Disease

Thassio Mesquita iD, Yen-Nien Lin iD, Shuang Chen iD, Youngho Lee iD, Rodrigo Miguel-Dos-Santos, Asli E Atici iD, Michael C Fishbein iD, Magali Noval Rivas iD, Moshe Arditi iD, Eugenio Cingolani iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-04 · 44 (4)

DOI: 10.1161/atvbaha.123.320382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-04. Verfasst von Thassio Mesquita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Smidt Heart Institute (T.M., Y.-N.L., R.M.-d.-S., M.A., E.C.), Cedars-Sinai Medical Center, Los Angeles, CA. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, Vasculitis, Cardiomyopathies, Tachycardia, Ventricular. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Kawasaki disease (KD) is an acute febrile illness and systemic vasculitis often associated with cardiac sequelae, including arrhythmias. Abundant evidence indicates a central role for IL (interleukin)-1 and TNFα (tumor necrosis factor-alpha) signaling in the formation of arterial lesions in KD. We aimed to investigate the mechanisms underlying the development of electrophysiological abnormalities in a murine model of KD vasculitis. METHODS: Lactobacillus casei cell wall extract–induced KD vasculitis model was used to investigate the therapeutic efficacy of clinically relevant IL-1Ra (IL-1 receptor antagonist) and TNFα neutralization. Echocardiography, in vivo electrophysiology, whole-heart optical mapping, and imaging were performed. RESULTS: KD vasculitis was associated with impaired ejection fraction, increased ventricular tachycardia, prolonged repolarization, and slowed conduction velocity. Since our transcriptomic analysis of human patients showed elevated levels of both IL-1β and TNFα, we asked whether either cytokine was linked to the development of myocardial dysfunction. Remarkably, only inhibition of IL-1 signaling by IL-1Ra but not TNFα neutralization was able to prevent changes in ejection fraction and arrhythmias, whereas both IL-1Ra and TNFα neutralization significantly improved vasculitis and heart vessel inflammation. The treatment of L casei cell wall extract–injected mice with IL-1Ra also restored conduction velocity and improved the organization of Cx43 (connexin 43) at the intercalated disk. In contrast, in mice with gain of function of the IL-1 signaling pathway, L casei cell wall extract induced spontaneous ventricular tachycardia and premature deaths. CONCLUSIONS: Our results characterize the electrophysiological abnormalities associated with L casei cell wall extract–induced KD and show that IL-1Ra is more effective in preventing KD-induced myocardial dysfunction and arrhythmias than anti-TNFα therapy. These findings support the advancement of clinical trials using IL-1Ra in patients with KD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucocutaneous Lymph Node SyndromeVasculitisCardiomyopathiesTachycardia, VentricularHumansAnimalsMiceInterleukin 1 Receptor Antagonist ProteinTumor Necrosis Factor-alphaDisease Models, AnimalInterleukin-1betaArrhythmias, Cardiac

Stichwörter der Autor:innen

Kawasaki diseasecardiac arrhythmiasinterleukin-1interleukin-1 receptor antagonist proteinvasculitis

Substanzen

Interleukin 1 Receptor Antagonist ProteinTumor Necrosis Factor-alphaInterleukin-1beta

Autor:innen und Institutionen

  • Smidt Heart Institute (T.M., Y.-N.L., R.M.-d.-S., M.A., E.C.), Cedars-Sinai Medical Center, Los Angeles, CA.
  • Infectious and Immunologic Diseases Research Center and Department of Biomedical Sciences (S.C., Y.L., A.E.A., M.N.R., M.A.), Cedars-Sinai Medical Center, Los Angeles, CA.
  • Department of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA (S.C., Y.L., A.E.A., M.N.R., M.A.).
  • Department of Pathology, David Geffen School of Medicine at UCLA (M.C.F.).

ORCID-Profile: Thassio Mesquita, Yen-Nien Lin, Shuang Chen, Youngho Lee, Asli E Atici, Michael C Fishbein, Magali Noval Rivas, Moshe Arditi, Eugenio Cingolani

Förderung

  • American Heart Association-American Stroke Association
  • NIAID NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Mesquita, T., Lin, Y. N., Chen, S., Lee, Y., Miguel-Dos-Santos, R., Atici, A. E., Fishbein, M. C., Noval Rivas, M., Arditi, M., & Cingolani, E. (2024). Inhibition of IL-1 Ameliorates Cardiac Dysfunction and Arrhythmias in a Murine Model of Kawasaki Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(4). https://doi.org/10.1161/atvbaha.123.320382

Vancouver

Mesquita T, Lin YN, Chen S, Lee Y, Miguel-Dos-Santos R, Atici AE, et al. Inhibition of IL-1 Ameliorates Cardiac Dysfunction and Arrhythmias in a Murine Model of Kawasaki Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(4). doi:10.1161/atvbaha.123.320382

BibTeX
@article{Mesquita2024,
  author = {Mesquita, Thassio and Lin, Yen-Nien and Chen, Shuang and Lee, Youngho and Miguel-Dos-Santos, Rodrigo and Atici, Asli E and Fishbein, Michael C and Noval Rivas, Magali and Arditi, Moshe and Cingolani, Eugenio},
  title = {Inhibition of IL-1 Ameliorates Cardiac Dysfunction and Arrhythmias in a Murine Model of Kawasaki Disease},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  volume = {44},
  number = {4},
  doi = {10.1161/atvbaha.123.320382}
}
Kostenlos starten →